127 related articles for article (PubMed ID: 9510347)
1. Distinction between symptoms of voiding and filling in benign prostatic hyperplasia: findings from the Health Professionals Follow-up Study.
Welch G; Kawachi I; Barry MJ; Giovannucci E; Colditz GA; Willett WC
Urology; 1998 Mar; 51(3):422-7. PubMed ID: 9510347
[TBL] [Abstract][Full Text] [Related]
2. Filling and voiding symptoms in the American Urological Association symptom index: the value of their distinction in a Veterans Affairs randomized trial of medical therapy in men with a clinical diagnosis of benign prostatic hyperplasia.
Barry MJ; Williford WO; Fowler FJ; Jones KM; Lepor H
J Urol; 2000 Nov; 164(5):1559-64. PubMed ID: 11025704
[TBL] [Abstract][Full Text] [Related]
3. Correlation of American Urological Association symptom index with obstructive and nonobstructive prostatism.
Yalla SV; Sullivan MP; Lecamwasam HS; DuBeau CE; Vickers MA; Cravalho EG
J Urol; 1995 Mar; 153(3 Pt 1):674-9; discussion 679-80. PubMed ID: 7532231
[TBL] [Abstract][Full Text] [Related]
4. Correlation between voiding and erectile function in patients with symptomatic benign prostatic hyperplasia.
Huang WJ; Chen KK; Chang LS
J Chin Med Assoc; 2005 Apr; 68(4):178-82. PubMed ID: 15850068
[TBL] [Abstract][Full Text] [Related]
5. Use of Structural Equation Modeling to Demonstrate the Differential Impact of Storage and Voiding Lower Urinary Tract Symptoms on Symptom Bother and Quality of Life during Treatment for Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia.
McVary KT; Peterson A; Donatucci CF; Baygani S; Henneges C; Clouth J; Wong D; Oelke M
J Urol; 2016 Sep; 196(3):824-30. PubMed ID: 27105760
[TBL] [Abstract][Full Text] [Related]
6. Effect of terazosin on clinical benign prostatic hyperplasia in older adults.
Mudiyala R; Ahmed A
J Am Geriatr Soc; 2003 Mar; 51(3):424-6. PubMed ID: 12588590
[TBL] [Abstract][Full Text] [Related]
7. Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
McVary KT; Rademaker A; Lloyd GL; Gann P
J Urol; 2005 Oct; 174(4 Pt 1):1327-433. PubMed ID: 16145413
[TBL] [Abstract][Full Text] [Related]
8. American Urological Association symptom index for women with voiding symptoms: lack of index specificity for benign prostate hyperplasia.
Chancellor MB; Rivas DA
J Urol; 1993 Nov; 150(5 Pt 2):1706-8; discussion 1708-9. PubMed ID: 7692106
[TBL] [Abstract][Full Text] [Related]
9. Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study.
Roehrborn CG; Issa MM; Bruskewitz RC; Naslund MJ; Oesterling JE; Perez-Marrero R; Shumaker BP; Narayan P
Urology; 1998 Mar; 51(3):415-21. PubMed ID: 9510346
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and predictive value of voiding diary data versus prostate volume, maximal free urinary flow rate, and Abrams-Griffiths number in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
van Venrooij GE; van Melick HH; Eckhardt MD; Boon TA
Urology; 2008 Mar; 71(3):469-74. PubMed ID: 18342189
[TBL] [Abstract][Full Text] [Related]
11. Early improvement of storage or voiding symptoms by tadalafil predicts treatment outcomes in patients with lower urinary tract symptoms from benign prostatic hyperplasia.
Yokoyama O; Ozeki A; Suzuki N; Murakami M
Int J Urol; 2018 Mar; 25(3):240-245. PubMed ID: 29094398
[TBL] [Abstract][Full Text] [Related]
12. Predictability of irritative voiding symptoms following photoselective laser vaporization of the prostate.
Matoka DJ; Averch TD
Can J Urol; 2007 Oct; 14(5):3710-4. PubMed ID: 17949529
[TBL] [Abstract][Full Text] [Related]
13. The symptom questionnaire for benign prostatic hyperplasia: an ambiguous indicator for an ambiguous disease.
Stoevelaar HJ; van de Beek C; Nijs HG; Casparie AF; McDonnell J; Janknegt RA
Br J Urol; 1996 Feb; 77(2):181-5. PubMed ID: 8800881
[TBL] [Abstract][Full Text] [Related]
14. The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator Group.
Roehrborn CG; Oesterling JE; Auerbach S; Kaplan SA; Lloyd LK; Milam DE; Padley RJ
Urology; 1996 Feb; 47(2):159-68. PubMed ID: 8607227
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for progression or improvement of lower urinary tract symptoms in a prospective cohort of men.
Martin S; Lange K; Haren MT; Taylor AW; Wittert G;
J Urol; 2014 Jan; 191(1):130-7. PubMed ID: 23770136
[TBL] [Abstract][Full Text] [Related]
16. Content validity of the Benign Prostatic Hyperplasia Impact Index (BII); a measure of how urinary trouble and problems associated with BPH may impact the patient.
Kingery L; Martin ML; Naegeli AN; Khan S; Viktrup L
Int J Clin Pract; 2012 Sep; 66(9):883-90. PubMed ID: 22897465
[TBL] [Abstract][Full Text] [Related]
17. Effect of tadalafil on male lower urinary tract symptoms: an integrated analysis of storage and voiding international prostate symptom subscores from four randomised controlled trials.
Chapple CR; Roehrborn CG; McVary K; Ilo D; Henneges C; Viktrup L
Eur Urol; 2015 Jan; 67(1):114-122. PubMed ID: 25301757
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive patient evaluation for benign prostatic hyperplasia.
Jepsen JV; Bruskewitz RC
Urology; 1998 Apr; 51(4A Suppl):13-8. PubMed ID: 9586591
[TBL] [Abstract][Full Text] [Related]
19. Effect of scrambling on the short-term reliability of the American Urological Association Symptom Index.
Barnboym E; Ahrens A; Roehrborn CG
Urology; 1999 Mar; 53(3):568-73. PubMed ID: 10096386
[TBL] [Abstract][Full Text] [Related]
20. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
